Tamoxifen Pharmacogenetics in Asian Breast Cancer Women (Tamoxifen)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01181518
Verified May 2013 by Jae-Gook Shin, Inje University. Recruitment status was: Recruiting
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Breast cancer patients who underwent surgery at Busan Paik Hospital, Inje University
incident breast cancer patients who underwent surgery
previous cancer history before breast cancer diagnosis